Oscar Health Statistics
Total Valuation
Oscar Health has a market cap or net worth of $6.41 billion. The enterprise value is $2.09 billion.
Important Dates
The last earnings date was Wednesday, May 6, 2026, before market open.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Oscar Health has 300.81 million shares outstanding. The number of shares has increased by 1.94% in one year.
| Current Share Class | 265.22M |
| Shares Outstanding | 300.81M |
| Shares Change (YoY) | +1.94% |
| Shares Change (QoQ) | +16.42% |
| Owned by Insiders (%) | 5.12% |
| Owned by Institutions (%) | 54.01% |
| Float | 246.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 17.42 |
| PS Ratio | 0.48 |
| Forward PS | 0.33 |
| PB Ratio | 3.83 |
| P/TBV Ratio | 3.85 |
| P/FCF Ratio | 2.29 |
| P/OCF Ratio | 2.26 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 52.46, with an EV/FCF ratio of 0.75.
| EV / Earnings | n/a |
| EV / Sales | 0.16 |
| EV / EBITDA | 52.46 |
| EV / EBIT | 196.82 |
| EV / FCF | 0.75 |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.09 |
| Quick Ratio | 1.07 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 8.76 |
| Debt / FCF | 0.17 |
| Interest Coverage | 0.62 |
Financial Efficiency
Return on equity (ROE) is -2.62% and return on invested capital (ROIC) is 0.58%.
| Return on Equity (ROE) | -2.62% |
| Return on Assets (ROA) | 0.09% |
| Return on Invested Capital (ROIC) | 0.58% |
| Return on Capital Employed (ROCE) | 0.49% |
| Weighted Average Cost of Capital (WACC) | 16.12% |
| Revenue Per Employee | $5.77M |
| Profits Per Employee | -$17,105 |
| Employee Count | 2,305 |
| Asset Turnover | 1.76 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Oscar Health has paid $12.65 million in taxes.
| Income Tax | 12.65M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +25.21% in the last 52 weeks. The beta is 2.34, so Oscar Health's price volatility has been higher than the market average.
| Beta (5Y) | 2.34 |
| 52-Week Price Change | +25.21% |
| 50-Day Moving Average | 14.82 |
| 200-Day Moving Average | 16.07 |
| Relative Strength Index (RSI) | 82.71 |
| Average Volume (20 Days) | 6,858,542 |
Short Selling Information
The latest short interest is 26.16 million, so 8.70% of the outstanding shares have been sold short.
| Short Interest | 26.16M |
| Short Previous Month | 26.34M |
| Short % of Shares Out | 8.70% |
| Short % of Float | 10.63% |
| Short Ratio (days to cover) | 3.89 |
Income Statement
In the last 12 months, Oscar Health had revenue of $13.30 billion and -$39.43 million in losses. Loss per share was -$0.15.
| Revenue | 13.30B |
| Gross Profit | 2.31B |
| Operating Income | 10.61M |
| Pretax Income | -26.74M |
| Net Income | -39.43M |
| EBITDA | 39.79M |
| EBIT | 10.61M |
| Loss Per Share | -$0.15 |
Full Income StatementBalance Sheet
The company has $6.80 billion in cash and $482.24 million in debt, with a net cash position of $4.32 billion or $14.37 per share.
| Cash & Cash Equivalents | 6.80B |
| Total Debt | 482.24M |
| Net Cash | 4.32B |
| Net Cash Per Share | $14.37 |
| Equity (Book Value) | 1.67B |
| Book Value Per Share | 5.57 |
| Working Capital | 636.95M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $2.84 billion and capital expenditures -$36.14 million, giving a free cash flow of $2.80 billion.
| Operating Cash Flow | 2.84B |
| Capital Expenditures | -36.14M |
| Depreciation & Amortization | n/a |
| Net Borrowing | 371.12M |
| Free Cash Flow | 2.80B |
| FCF Per Share | $9.31 |
Full Cash Flow StatementMargins
Gross margin is 17.39%, with operating and profit margins of 0.08% and -0.30%.
| Gross Margin | 17.39% |
| Operating Margin | 0.08% |
| Pretax Margin | -0.20% |
| Profit Margin | -0.30% |
| EBITDA Margin | 0.30% |
| EBIT Margin | 0.08% |
| FCF Margin | 21.04% |
Dividends & Yields
Oscar Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.94% |
| Shareholder Yield | -1.94% |
| Earnings Yield | -0.62% |
| FCF Yield | 43.67% |
Analyst Forecast
The average price target for Oscar Health is $18.25, which is -14.36% lower than the current price. The consensus rating is "Hold".
| Price Target | $18.25 |
| Price Target Difference | -14.36% |
| Analyst Consensus | Hold |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |
